QID 91925

QID 91925: Microsoft Azure Site Recovery Multiple Vulnerabilities Security Update for July 2022

Azure Site Recovery helps ensure business continuity by keeping business apps and workloads running during outages. It is a service but also has a few on-premise components.
Azure Site Recovery is prone to multiple vulnerabilities.

Affected Software:
Azure Site Recovery Version Prior to 9.49

Successful exploitation allows attacker to elevate privileges

CVSS V3 rated as Critical - 8.8 severity.

CVSS V2 rated as High - 6.5 severity.

Solution

Customers are advised to refer to Azure Site recovery rollup

Vendor References

Azure Site Recovery - support.microsoft.com/en-us/topic/update-rollup-62-for-azure-site-recovery-e7aff36f-b6ad-4705-901c-f662c00c402b

CVEs related to QID 91925

CVE-2022-30181 | CVE-2022-33641 | CVE-2022-33673 | CVE-2022-33674 | CVE-2022-33675 | CVE-2022-33676 | CVE-2022-33677 | CVE-2022-33678 | CVE-2022-33642 | CVE-2022-33643 | CVE-2022-33650 | CVE-2022-33651 | CVE-2022-33652 | CVE-2022-33653 | CVE-2022-33654 | CVE-2022-33655 | CVE-2022-33656 | CVE-2022-33657 | CVE-2022-33658 | CVE-2022-33659 | CVE-2022-33660 | CVE-2022-33661 | CVE-2022-33662 | CVE-2022-33663 | CVE-2022-33664 | CVE-2022-33665 | CVE-2022-33666 | CVE-2022-33667 | CVE-2022-33668 | CVE-2022-33669 | CVE-2022-33671 | CVE-2022-33672 |

Software Advisories

Advisory ID	Software	Component	Link
Azure site recovery 62 rollup			support.microsoft.com/en-us/topic/update-rollup-62-for-azure-site-recovery-e7aff36f-b6ad-4705-901c-f662c00c402b

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].